Nifty
Sensex
:
:
11600.20
39090.03
326.00 (2.89%)
1075.41 (2.83%)

Pharmaceuticals & Drugs

Rating :
71/99

BSE: 540145 | NSE: Not Listed

1501.25
20-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  1448.00
  •  1503.20
  •  1448.00
  •  1461.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  15
  •  33.35
  •  1999.90
  •  985.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,823.90
  • 13.69
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,902.90
  • 0.80%
  • 7.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 45.96%
  • 2.13%
  • 50.63%
  • FII
  • DII
  • Others
  • 0%
  • 0.73%
  • 0.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Net Sales
-
692.30
Net Sales Growth
-
 
Cost Of Goods Sold
-
393.52
Gross Profit
-
298.78
GP Margin
-
43.16%
Total Expenditure
-
512.12
Power & Fuel Cost
-
39.42
% Of Sales
-
5.69%
Employee Cost
-
18.48
% Of Sales
-
2.67%
Manufacturing Exp.
-
40.68
% Of Sales
-
5.88%
General & Admin Exp.
-
6.08
% Of Sales
-
0.88%
Selling & Distn. Exp.
-
10.94
% Of Sales
-
1.58%
Miscellaneous Exp.
-
3.00
% Of Sales
-
0.43%
EBITDA
-
180.18
EBITDA Margin
-
26.03%
Other Income
-
8.73
Interest
-
4.06
Depreciation
-
13.64
PBT
-
171.21
Tax
-
49.96
Tax Rate
-
27.27%
PAT
-
133.24
PAT before Minority Interest
-
133.22
Minority Interest
-
0.02
PAT Margin
-
19.25%
PAT Growth
-
 
Unadjusted EPS
-
109.67

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Shareholder's Funds
259.37
Share Capital
5.86
Total Reserves
245.00
Non-Current Liabilities
59.71
Secured Loans
21.79
Unsecured Loans
22.46
Long Term Provisions
2.59
Current Liabilities
117.49
Trade Payables
74.28
Other Current Liabilities
8.12
Short Term Borrowings
32.66
Short Term Provisions
2.44
Total Liabilities
448.20
Net Block
149.69
Gross Block
229.26
Accumulated Depreciation
79.56
Non Current Assets
229.73
Capital Work in Progress
65.56
Non Current Investment
1.81
Long Term Loans & Adv.
12.67
Other Non Current Assets
0.00
Current Assets
218.47
Current Investments
10.47
Inventories
47.91
Sundry Debtors
141.38
Cash & Bank
3.64
Other Current Assets
15.07
Short Term Loans & Adv.
13.95
Net Current Assets
100.97
Total Assets
448.20

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Cash From Operating Activity
39.49
PBT
171.21
Adjustment
12.20
Changes in Working Capital
-115.00
Cash after chg. in Working capital
68.41
Interest Paid
0.00
Tax Paid
-40.89
Other Direct Exp. Paid
0.00
Extra & Other Items
11.97
Cash From Investing Activity
-42.17
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
-8.56
Net Cash Inflow / Outflow
-11.24
Opening Cash & Equivalents
12.56
Closing Cash & Equivalent
3.64

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Book Value (Rs.)
427.78
ROA
29.72%
ROE
53.10%
ROCE
54.75%
Fixed Asset Turnover
3.02
Receivable days
74.54
Inventory Days
25.26
Payable days
52.23
Cash Conversion Cycle
47.57
Total Debt/Equity
0.33
Interest Cover
46.14

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.